The city’s new Medical Devices Commercialization Centre has appointed Richard Meadows as its first chief operating officer, the centre announced on Wednesday.
Mr. Meadows comes to the centre with experience in commercialization of medical devices in the biopharmaceutical industry, including stints with major companies such as Bristol Myers and Procter & Gamble.
He was CEO of DERMACOR, the first wound care company in Canada, and most recently has been involved with venture capital firms investing in the life sciences sector.
(Sponsored)
New Sprott School of Business Strategic Plan based on shared community prosperity
Montreal-born finance professor Howard Nemiroff says he didn’t necessarily expect to take a leadership role after returning to Canada in 2006, following several years abroad. Nemiroff says he was content
CarMa Institute is quietly powering the next wave of biotech from The ByWard Market
In the heart of Ottawa’s ByWard Market, a new kind of investor relations and capital strategy firm is reshaping how biotech innovation finds its way to global investors. Founded by
In 2013, Forbes magazine recognized Mr. Meadows, who co-founded the CTI Life Sciences Fund, as one of the top 10 life sciences investors in North America.
